Bloovi interview
1 August 2023

At myNEO Therapeutics we are devoted to finding new and better targets for immunotherapy. With our validated technology, our amazing team, and our continuous appetite for innovation, we continue this exciting path to improve cancer care for patients.

Thanks Bloovi for this nice article (in Dutch) where Bert Coessens talks about myNEO Therapeutics’ differentiators and goals for the upcoming years.